Ongoing Digital Monitoring Could Make Immunotherapy More Accessible
Ongoing digital monitoring could be about to solve one of modern medicine's most frustrating access problems. Life-extending cancer immunotherapies exist and there are numerous patients who could benefit from such therapies, but a mandatory hospital stay requirement currently makes access to immunotherapy nigh impossible for rural and underserved patients. However, a growing body of evidence now suggests that continuous remote monitoring could remove the need for hospital stays post immunotherapy. CAR-T cell therapies and related immunotherapies have reshaped what is possible for patients with certain blood cancers, producing remission rates that were unthinkable a generation ago. Thirteen of these treatments now carry FDA approval across two therapy categories. Getting them to patients,…
